208 related articles for article (PubMed ID: 30082888)
1. Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion.
Liu JJ; Chiu YT; DiMattio KM; Chen C; Huang P; Gentile TA; Muschamp JW; Cowan A; Mann M; Liu-Chen LY
Neuropsychopharmacology; 2019 Apr; 44(5):939-949. PubMed ID: 30082888
[TBL] [Abstract][Full Text] [Related]
2. Quantification of observable behaviors induced by typical and atypical kappa-opioid receptor agonists in male rhesus monkeys.
Huskinson SL; Platt DM; Brasfield M; Follett ME; Prisinzano TE; Blough BE; Freeman KB
Psychopharmacology (Berl); 2020 Jul; 237(7):2075-2087. PubMed ID: 32372348
[TBL] [Abstract][Full Text] [Related]
3. Agonist-promoted kappa opioid receptor (KOR) phosphorylation has behavioral endpoint-dependent and sex-specific effects.
Huang P; Chen C; Cao D; Huang M; Liu-Chen LY
Neuropharmacology; 2022 Jan; 202():108860. PubMed ID: 34736959
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cocaine-related behaviors by low doses of the potent KOR agonist nalfurafine in male C57BL6 mice.
Dunn A; Windisch K; Ben-Ezra A; Pikus P; Morochnik M; Erazo J; Reed B; Kreek MJ
Psychopharmacology (Berl); 2020 Aug; 237(8):2405-2418. PubMed ID: 32435819
[TBL] [Abstract][Full Text] [Related]
5. Preclinical Studies on Nalfurafine (TRK-820), a Clinically Used KOR Agonist.
Zhou Y; Freeman K; Setola V; Cao D; Kaski S; Kreek MJ; Liu-Chen LY
Handb Exp Pharmacol; 2022; 271():137-162. PubMed ID: 33834276
[TBL] [Abstract][Full Text] [Related]
6. Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo.
Wang Y; Tang K; Inan S; Siebert D; Holzgrabe U; Lee DY; Huang P; Li JG; Cowan A; Liu-Chen LY
J Pharmacol Exp Ther; 2005 Jan; 312(1):220-30. PubMed ID: 15383632
[TBL] [Abstract][Full Text] [Related]
7. In vivo brain GPCR signaling elucidated by phosphoproteomics.
Liu JJ; Sharma K; Zangrandi L; Chen C; Humphrey SJ; Chiu YT; Spetea M; Liu-Chen LY; Schwarzer C; Mann M
Science; 2018 Jun; 360(6395):. PubMed ID: 29930108
[TBL] [Abstract][Full Text] [Related]
8. The Protective Effects of Κ-Opioid Receptor Stimulation in Hypoxic Pulmonary Hypertension Involve Inhibition of Autophagy Through the AMPK-MTOR Pathway.
Zhou Y; Wang Y; Wang X; Tian X; Zhang S; Yang F; Guo H; Fan R; Feng N; Jia M; Gu X; Wang Y; Li J; Pei J
Cell Physiol Biochem; 2017; 44(5):1965-1979. PubMed ID: 29224002
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the diuretic effects of chemically diverse kappa opioid agonists in rats: nalfurafine, U50,488H, and salvinorin A.
Inan S; Lee DY; Liu-Chen LY; Cowan A
Naunyn Schmiedebergs Arch Pharmacol; 2009 Mar; 379(3):263-70. PubMed ID: 18925386
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of differences in (-)(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl]benzeneacetamide-induced desensitization and phosphorylation between human and rat kappa-opioid receptors expressed in Chinese hamster ovary cells.
Li J; Li JG; Chen C; Zhang F; Liu-Chen LY
Mol Pharmacol; 2002 Jan; 61(1):73-84. PubMed ID: 11752208
[TBL] [Abstract][Full Text] [Related]
11. Novel selective κ agonists SLL-039 and SLL-1206 produce potent antinociception with fewer sedation and aversion.
Wei YY; Ma Y; Yao SY; Kong LH; Liu X; Chai JR; Chen J; Li W; Wang YJ; Shao LM; Liu JG
Acta Pharmacol Sin; 2022 Jun; 43(6):1372-1382. PubMed ID: 34493813
[TBL] [Abstract][Full Text] [Related]
12. The kappa-opioid receptor agonist, triazole 1.1, reduces oxycodone self-administration and enhances oxycodone-induced thermal antinociception in male rats.
Zamarripa CA; Pareek T; Schrock HM; Prisinzano TE; Blough BE; Sufka KJ; Freeman KB
Psychopharmacology (Berl); 2021 Dec; 238(12):3463-3476. PubMed ID: 34430992
[TBL] [Abstract][Full Text] [Related]
13. Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor.
Schattauer SS; Kuhar JR; Song A; Chavkin C
Cell Signal; 2017 Apr; 32():59-65. PubMed ID: 28088389
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological and phosphoproteomic approaches to roles of protein kinase C in kappa opioid receptor-mediated effects in mice.
Liu JJ; Chiu YT; Chen C; Huang P; Mann M; Liu-Chen LY
Neuropharmacology; 2020 Dec; 181():108324. PubMed ID: 32976891
[TBL] [Abstract][Full Text] [Related]
15. The G-protein biased kappa opioid agonists, triazole 1.1 and nalfurafine, produce non-uniform behavioral effects in male rhesus monkeys.
Huskinson SL; Platt DM; Zamarripa CA; Dunaway K; Brasfield M; Prisinzano TE; Blough BE; Freeman KB
Pharmacol Biochem Behav; 2022 Jun; 217():173394. PubMed ID: 35513117
[TBL] [Abstract][Full Text] [Related]
16. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
Ehrich JM; Messinger DI; Knakal CR; Kuhar JR; Schattauer SS; Bruchas MR; Zweifel LS; Kieffer BL; Phillips PE; Chavkin C
J Neurosci; 2015 Sep; 35(37):12917-31. PubMed ID: 26377476
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administration behavior.
Wang YJ; Tao YM; Li FY; Wang YH; Xu XJ; Chen J; Cao YL; Chi ZQ; Neumeyer JL; Zhang A; Liu JG
J Pharmacol Exp Ther; 2009 Apr; 329(1):306-13. PubMed ID: 19136637
[TBL] [Abstract][Full Text] [Related]
18. Agonist-Promoted Phosphorylation and Internalization of the Kappa Opioid Receptor in Mouse Brains: Lack of Connection With Conditioned Place Aversion.
Chen C; Huang P; Bland K; Li M; Zhang Y; Liu-Chen LY
Front Pharmacol; 2022; 13():835809. PubMed ID: 35652052
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus.
Morgenweck J; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
Neuropharmacology; 2015 Dec; 99():600-9. PubMed ID: 26318102
[TBL] [Abstract][Full Text] [Related]
20. Agonist-Dependent and -Independent κ Opioid Receptor Phosphorylation: Distinct Phosphorylation Patterns and Different Cellular Outcomes.
Chiu YT; Chen C; Yu D; Schulz S; Liu-Chen LY
Mol Pharmacol; 2017 Nov; 92(5):588-600. PubMed ID: 28893975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
